Whole Genome and Transcriptome Analysis of Thyroid Cancers

甲状腺癌的全基因组和转录组分析

• 批准号: 283842
• 负责人: Kasaian Katayoon
• 金额: $ 7.65万
• 依托单位: Genome Sciences Centre
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-10-01 至 2015-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=283842&lang=en
• 关键词: Bioinformatics; Biostatistics; De-Novo Assembly; Detection Of Novel Somatic Mutations; Diagnoastic; Next Generation Sequencing; Prognostic And Predictive Marker Identification; Software Engineering; Thyroid Cancers; Tissue Microarray Analysis; Whole Genom

An estimated 4% to 7% of the population will develop a clinically significant thyroid tumor during their lifetime. In many cases, diagnosis results from standard techniques are inconclusive and so a large proportion of individuals undergo surgery as a dia

据估计，4% 至 7% 的人口在其一生中会患上具有临床意义的甲状腺肿瘤。在许多情况下，标准技术的诊断结果是不确定的，因此很大一部分人接受手术作为诊断